Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesTransplantation ConditioningHematopoietic Stem Cell TransplantationAnemia, AplasticLeukemiaTransplantation ChimeraLiver TransplantationTissue DonorsGraft SurvivalBusulfanBone Marrow PurgingHistocompatibilityHistocompatibility TestingHematopoietic Stem CellsCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesHematologic NeoplasmsKidney TransplantationRecurrenceHematopoiesisCombined Modality TherapyMice, Inbred C57BLRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveImmunosuppressive AgentsLeukemia, Myeloid, AcuteTreatment OutcomeBone Marrow ExaminationRemission InductionPrecursor Cell Lymphoblastic Leukemia-LymphomaGraft RejectionTime FactorsHepatic Veno-Occlusive DiseaseGraft vs Host ReactionTransplantation ImmunologyAcute DiseaseLymphocyte DepletionBone RemodelingLeukemia, MyeloidLymphoma, Non-HodgkinLeukocyte TransfusionBone Marrow NeoplasmsImmunosuppressionStem Cell TransplantationT-LymphocytesRetrospective StudiesSurvival AnalysisHeart TransplantationHLA AntigensMyelodysplastic SyndromesLymphocyte TransfusionChimeraSevere Combined ImmunodeficiencyGraft vs Leukemia EffectColony-Forming Units AssayHematologic DiseasesGraft vs Tumor EffectActuarial AnalysisLung TransplantationCyclosporineNuclear FamilyAntineoplastic Combined Chemotherapy ProtocolsBone DensitySurvival RateFollow-Up StudiesLymphomaCarmustinePancytopeniaOrgan TransplantationCell DifferentiationMice, Inbred BALB CLeukocyte CountSpleenCytomegalovirus InfectionsDisease-Free SurvivalCytarabineGranulocyte Colony-Stimulating FactorMultiple MyelomaMelphalanFlow CytometryBone ResorptionEtoposideFatal OutcomePrognosisHodgkin DiseaseCord Blood Stem Cell TransplantationCells, CulturedAntilymphocyte SerumInfectionAntigens, CD34Mice, KnockoutPeripheral Blood Stem Cell Transplantation